# Koge

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/koge

- Industry: Food
- Headquarters: Toronto, Canada
- Website: www.kogevitamins.com
- Total disclosed funding: $0.1M
- Latest round: Seed (Jul 15, 2013)
- Investors on record: 1

## About

Koge develops advanced vitamin supplements aimed at enhancing consumer health and wellness, leveraging cutting-edge research in nutrition to create effective products for a diverse clientele.Koge is focused on producing high-quality vitamin supplements that cater to individual health needs. The company has maintained a consistent business strategy since its inception in Toronto, Canada, and operates independently without any known subsidiaries. Koge was founded by a team of health enthusiasts with backgrounds in nutrition and wellness. In July 2013, Koge successfully raised CAD 0.15 mn in Seed financing from BDC Capital, marking its first funding round and the total amount raised to date.Koge specializes in vitamin supplements designed to improve overall health and wellness. Their product line includes a range of vitamins targeting specific health concerns, utilizing the latest research to ensure efficacy. These products are aimed at health-conscious consumers seeking reliable supplementation to support their daily nutritional needs. Koge emphasizes the importance of quality ingredients and scientific backing in their offerings, establishing a reputation in the health products market.Koge’s revenue model is primarily based on direct-to-consumer sales through online channels, where customers can purchase their vitamin supplements via subscriptions or one-time orders. This model allows Koge to maintain a steady revenue stream as customers often return for additional purchases due to the ongoing demand for health supplements. The tiered pricing structure ensures affordability and accessibility for individual and family needs, contributing to a sustainable business growth.Koge is planning to expand its product line with new vitamin supplements set to launch in late 2024, targeting specific health trends identified in market research. The company aims to enter new geographic regions, particularly the European and Asian markets, by 2025, capitalizing on the increasing demand for health supplements in these areas. The recent Seed funding of CAD 0.15 mn will support research and development of these new products, as well as marketing efforts to establish a presence in the targeted regions.

## Funding rounds

- Seed, Jul 15, 2013, $0.1M — BDC Capital

## Investors

- BDC Capital (https://capitalatlas.ai/funds/bdc-capital) — Seed